1. Stocks
    2. /
  2. CSL (ASX: CSL)
    3. /

CSL (ASX: CSL) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

CSL Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • CSL (ASX: CSL)
    Latest News

    a medical person in full protective gear with mask and gloves holds up a needle in one hand and a small bottle of vaccine in the other in a medical setting.
    Healthcare Shares

    What happened with CSL shares in November?

    | Bernd Struben

    November offered a pleasant reprieve for CSL shareholders. But why?

    Read more »

    Five young people sit in a row having fun and interacting with their mobile phones.
    Share Market News

    5 most-traded Australian shares last week

    | Samantha Menzies

    Find out if any of these shares are on your list.

    Read more »

    Broker checking out the share price oh his smartphone and laptop.
    Opinions

    CSL is a great company, but I think this ASX stock is a better investment

    | Tristan Harrison

    I think this ASX share looks like a much better buy than CSL today.

    Read more »

    Young man with a laptop in hand watching stocks and trends on a digital chart.
    Broker Notes

    Buy, hold, sell: CSL, DroneShield, and Northern Star shares

    | James Mickleboro

    Let's see how analysts rate these popular shares.

    Read more »

    Excited couple celebrating success while looking at smartphone.
    How to invest

    Why today's cheap ASX shares could double my money during the next bull market

    | James Mickleboro

    These shares could be the ones to buy if you are looking for undervalued options.

    Read more »

    Legendary share market investing expert and owner of Berkshire Hathaway, Warren Buffett.
    How to invest

    I'd listen to Warren Buffett's advice to buy undervalued ASX shares today

    | James Mickleboro

    The Oracle of Omaha knows a good deal when he sees one.

    Read more »

    Happy man holding Australian dollar notes, representing dividends.
    Growth Shares

    2 ASX stocks to help turn $100,000 into $1 million

    | James Mickleboro

    Let's see why these shares could be great compounders over the next decade and beyond.

    Read more »

    A surprised and curious male investor drinks black coffee while reading the latest news on rising ASX shares in the newspaper
    Broker Notes

    Macquarie reveals ASX 200 share tips in each market sector for 2026

    | Bronwyn Allen

    Macquarie predicts strong capital growth for these ASX 200 shares over the next 12 months.

    Read more »

    Medical workers examine an xray or scan in a hospital laboratory.
    Healthcare Shares

    Should I buy CSL shares in December?

    | Tristan Harrison

    After a big fall, is this now the time to jump on CSL shares?

    Read more »

    A group of businesspeople clapping.
    Blue Chip Shares

    My best ASX stocks to invest $2,000 in right now

    | James Mickleboro

    Brokers sees significant value in these beaten down stocks.

    Read more »

    Biotechnology spelt out on green blocks.
    Healthcare Shares

    Are CSL shares a buy amid the company's $500 million cost-cutting plans?

    | Bernd Struben

    A leading investment expert delivers his verdict on the outlook for CSL’s beaten-down shares.

    Read more »

    Young man with a laptop in hand watching stocks and trends on a digital chart.
    Broker Notes

    Buy, hold, sell: Sigma Healthcare, CSL, and Lynas shares

    | James Mickleboro

    Analysts have given their verdict on these shares.

    Read more »

    Frequently Asked Questions

    CSL was listed on the ASX in June 1994.

    CSL has paid twice yearly dividends every year since late 1997, a little over three years after the company’s initial listing on the ASX. Up until early 2005, CSL’s dividends were all fully franked. Since then, franking credits have been intermittent.

    Since 2021 CSL has paid an unfranked interim dividend in April and a 10% franked final dividend in September/October.

    CSL has a dividend reinvestment plan, however, it has not been active since 2004. Instead, CSL periodically executes share buybacks as a way of delivering additional returns for shareholders.

    CSL originally floated in 1994 at $2.30 per share. However, taking into account share buybacks, the adjusted entry price is equivalent to around 76 cents. 

    CSL ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About CSL

    CSL Limited (ASX: CSL) is an Australian-based global biotechnology company that develops and delivers biotherapies and vaccines to protect public health and help people with life-threatening medical conditions live full lives.

    CSL has been in operation for more than a century and was listed on the ASX in 1994. Today, the blue-chip healthcare company is one of the largest on the ASX.

    CSL’s operational businesses include CSL Behring, CSL Seqirus and CSL Vifor. Its Plasma business operates one of the largest plasma collection networks in the world. CSL is recognised for its global leadership in three main areas: rare and serious diseases, vaccine development, and iron deficiency and nephrology (kidney research).

    The company operates in over 40 countries, predominantly Australia, the United States, Germany, the United Kingdom, and Switzerland.

     

    Profile

    since

    Note